| Bioactivity | IMP 243 is a symmetric di-HSG (histamine-succinyl-glycine) bivalent hapten containing a Tscg-Cys ligand and two HSG groups. IMP 243 can be radiolabeled with 99mTc-pertechnetate. IMP 243 can be conjugated to other peptides to design bispecific antibodies (bsMAbs) for cancer research[1]. |
| Name | IMP 243 |
| CAS | 391267-29-1 |
| Formula | C57H86N20O14S2 |
| Molar Mass | 1339.55 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Sharkey RM, et al. A universal pretargeting system for cancer detection and therapy using bispecific antibody. Cancer Res. 2003 Jan 15;63(2):354-63. |
IMP 243
CAS: 391267-29-1 F: C57H86N20O14S2 W: 1339.55
IMP 243 is a symmetric di-HSG (histamine-succinyl-glycine) bivalent hapten containing a Tscg-Cys ligand and two HSG grou
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.